Which dialysis modality is best for patients with diabetic nephropathy?

被引：0

作者：

Alscher, M. D. ^{[1
]}

机构：

[1] Robert Bosch Krankenhaus gGmbH, Auerbachstr 110, D-70376 Stuttgart, Germany

来源：

NEPHROLOGE | 2020年 / 15卷 / 03期

关键词：

Type 2 diabetes mellitus; Diabetic nephropathies; Peritoneal dialysis; Mortality; Advanced glycation end products; STAGE KIDNEY-DISEASE; PERITONEAL-DIALYSIS; RENAL-DISEASE; RISK-FACTORS; SURVIVAL; HEMODIALYSIS; EPIDEMIOLOGY; ICODEXTRIN; MORTALITY; MELLITUS;

D O I：

10.1007/s11560-020-00425-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The numbers of patients with type 2 diabetes is increasing worldwide. Correspondingly, there are also more patients with diabetic nephropathy. The major goal is a preemptive kidney transplantation; however, if that is not feasible dialysis treatment is indicated. Older German guidelines recommended peritoneal dialysis (PD) as the modality of choice for patients with diabetes. The arguments were better survival in the first years of treatment, better preservation of residual renal function and other factors, such as quality of life and mobility. Nowadays, experts recommend an individualized selection regarding the choice of the modality of dialysis, even for diabetic patients. It is therefore astonishing that the numbers for PD in Germany are low. For patients who have received adequate clarification and have an open choice of procedure, the proportion of PD is around 30-50% and this should be the goal for patients with diabetes in the future.

引用

页码：163 / 167

页数：5

共 41 条

[1] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].

Adler, AI ;

Stevens, RJ ;

Manley, SE ;

Bilous, RW ;

Cull, CA ;

Holman, RR .

KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232

[2] Diabetespatienten mit terminaler NiereninsuffizienzWelches ist die beste Dialysetherapie?Diabetic patients with end-stage renal diseaseWhat is the best dialysis modality? [J].

M. D. Alscher .

Der Nephrologe, 2017, 12 (6) :420-425

[3]

[Anonymous], 2020, PROGR NAT VERS LEITL

[4]

[Anonymous], 2012, ATL CHRON KIDN DIS E

[5] DIFFERENCE IN THE EXPRESSION OF HORMONE RECEPTORS AND FIBROTIC MARKERS IN THE HUMAN PERITONEUM-IMPLICATIONS FOR THERAPEUTIC TARGETS TO PREVENT ENCAPSULATING PERITONEAL SCLEROSIS [J].

Braun, Niko ;

Fritz, Peter ;

Biegger, Dagmar ;

Kimmel, Martin ;

Reimold, Fabian ;

Ulmer, Christoph ;

Alscher, M. Dominik .

PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (03) :291-300

[6] Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials [J].

Cho, Yeoungjee ;

Johnson, David W. ;

Badve, Sunil ;

Craig, Jonathan C. ;

Strippoli, Giovanni F. K. ;

Wiggins, Kathryn J. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (07) :1899-1907

[7]

Chung SH, 2009, PERITON DIALYSIS INT, V29, pS132

[8] A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis [J].

Cooper, Bruce A. ;

Branley, Pauline ;

Bulfone, Liliana ;

Collins, John F. ;

Craig, Jonathan C. ;

Fraenkel, Margaret B. ;

Harris, Anthony ;

Johnson, David W. ;

Kesselhut, Joan ;

Li, Jing Jing ;

Luxton, Grant ;

Pilmore, Andrew ;

Tiller, David J. ;

Harris, David C. ;

Pollock, Carol A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (07) :609-619

[9] Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence [J].

Couchoud, Cecile ;

Bolignano, Davide ;

Nistor, Ionut ;

Jager, Kitty J. ;

Heaf, James ;

Heimburger, Olle ;

Van Biesen, Wim .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (02) :310-320

[10] Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients [J].

Davies, SJ .

KIDNEY INTERNATIONAL, 2004, 66 (06) :2437-2445

← 1 2 3 4 5 →